RTOG Foundation, Inc.
🇺🇸United States
Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
Phase 2
Completed
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 80
- Registration Number
- NCT00006386
- Locations
- 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States
🇺🇸Huntsville Hospital System, Huntsville, Alabama, United States